Amarin Corporation plc (AMRN)

About AMRN

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

80

Website

www.amarincorp.com

Fundamentals

1-day range

$13.92$14.13

Market cap

$298.68M

P/E (trailing)

—

P/E (forward)

14.36

EPS (trailing)

$-1.20

Dividend yield

—

Beta

0.77

Avg. volume

73.4K

Forecasts

1 analyst ratings

Amarin Corporation plc Competitors

Chosen by industry and closest market cap.

• AMRN

  Amarin Corporation plc

  $13.97

  ▼ 0.71%
  Market cap $298.68MP/E —
  $12.96$20.9
• IRD

  Opus Genetics Inc. Common Stock

  $3.7

  ▼ 3.90%
  Market cap $300.54MP/E —
  $1.17$5.81
• ORGO

  Organogenesis Holdings Inc. Class A Common Stock

  $1.74

  ▼ 0.00%
  Market cap $301.10MP/E 84.95
  $1.54$7.08
• FULC

  Fulcrum Therapeutics Inc. Common Stock

  $3.85

  ▲ 0.00%
  Market cap $283.06MP/E —
  $2.83$15.74
• VNDA

  Vanda Pharmaceuticals Inc. Common Stock

  $5.29

  ▼ 2.76%
  Market cap $314.51MP/E —
  $4.27$9.94
• BCYC

  Bicycle Therapeutics plc American Depositary Shares

  $4.21

  ▼ 2.77%
  Market cap $270.87MP/E —
  $3.75$9.16
• IMRX

  Immuneering Corporation Class A Common Stock

  $4.99

  ▼ 4.22%
  Market cap $269.79MP/E —
  $3.86$10.08

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading
  Yahoo · 8/12/2026
• TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
  Yahoo · 8/12/2026
• Amarin (AMRN) Q2 2026 Earnings Call Transcript
  Yahoo · 8/8/2026
• Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?
  Yahoo · 7/31/2026

• Peter L. Fishman · August 1, 2026 · Grant

  313
• Peter L. Fishman · August 1, 2026 · Tax Withholding

  155 @ $14.26
• Peter L. Fishman · August 1, 2026 · Option Exercise

  313
• David Paul Keenan · July 1, 2026 · Grant

  3.7K
• David Paul Keenan · July 1, 2026 · Tax Withholding

  1.9K @ $15.94
• David Paul Keenan · July 1, 2026 · Option Exercise

  3.7K
• Peter L. Fishman · July 1, 2026 · Grant

  2.4K
• Peter L. Fishman · July 1, 2026 · Tax Withholding

  1.2K @ $15.94
• Peter L. Fishman · July 1, 2026 · Option Exercise

  2.4K
• Jonathan Provoost · July 1, 2026 · Grant

  3.7K
• Jonathan Provoost · July 1, 2026 · Tax Withholding

  1.3K @ $15.94
• Jonathan Provoost · July 1, 2026 · Option Exercise

  3.7K
• Steven B. Ketchum · July 1, 2026 · Grant

  3.7K
• Steven B. Ketchum · July 1, 2026 · Tax Withholding

  1.9K @ $15.94
• Steven B. Ketchum · July 1, 2026 · Option Exercise

  3.7K

Institutional Ownership

March 31, 2026

Total shares held

4.67M

Total value held

$58.07M

Institutional holders

65